NCT01245556 Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma Status COMPLETED Phase PHASE1
NCT01245062 GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma Status COMPLETED Phase PHASE3
NCT01223248 Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01215500 Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer Status COMPLETED Phase PHASE1
NCT01213472 Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma Status COMPLETED Phase PHASE1
NCT01212276 A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma Status TERMINATED Phase PHASE1
NCT01205815 Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment Status RECRUITING Phase N/A
NCT01200342 Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma Status TERMINATED Phase PHASE2
NCT01174238 A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma Status COMPLETED Phase PHASE2
NCT01152788 Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma Status COMPLETED Phase PHASE2
NCT01149343 Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer Status COMPLETED Phase PHASE1
NCT01127594 Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion Status COMPLETED Phase PHASE1
NCT01123304 Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma Status TERMINATED Phase PHASE1